a monoclonal antibody that blocks the action of a cytokine called tumor necrosis factor alfa. it is being studied in the treatment and prevention of weight loss and loss of appetite in patients with advanced cancer. it belongs to the family of drugs called monoclonal antibodies.
出典:Wiktionary
From infl(ammatory) + -li- (“immunomodulating”) + -ximab (“chimeric monoclonal antibody”).
infliximab (uncountable)
出典:Wikipedia
出典:『Wikipedia』 (2011/07/01 01:37 UTC 版)
Infliximab (INN; trade name Remicade) is a monoclonal antibody against tumour necrosis factor alpha (TNFα). It is used to treat autoimmune diseases. Remicade is marketed by Centocor Ortho Biotech, Inc. (Centocor) in the USA, Mitsubishi Tanabe Pharma in Japan, Xian Janssen in China, and Schering-Plough (now part of Merck & Co) elsewhere.